Eyenovia EYEN 深 沪
已收盘 07-02 16:00:00 美东时间
15.82
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 15.82
- 总市值 5.31亿
- 52周最高 17.18
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.0318
- 委 比 0.00%
- 总股本 3356.86万
- 历史最高 17.18
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0318
- 每 手 1
- 风险率 2.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program
Eyenovia completes $50M PIPE to buy over 1M HYPE tokens at ~$34 each, becoming the first Nasdaq-listed company to run a validator on Hyperliquid. The company is on track for FDA registration of Optejet UFD in September and is exploring partnerships while planning a name change to Hyperion DeFi.
06-23 12:30
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group
Eyenovia, Inc. announces debt amendment with Avenue Capital and appoints Max Fiege as Strategic Advisor to support its HYPE token treasury strategy. The HYPE token powers Hyperliquid's blockchain, offering trading fee discounts and staking benefits. Eyenovia aims to capitalize on the growing digital asset ecosystem while advancing its ophthalmic innovations, providing shareholders exposure to HYPE's potential value growth.
06-18 12:32
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
Eyenovia completes a $50M private placement to acquire HYPE tokens for its blockchain reserve, appoints Hyunsu Jung as CIO, and plans a staking program to support Hyperliquid's ecosystem.
06-17 18:55
EYEN Shares Are Trading Higher Today: What You Need To Know
Eyenovia shares are surging Monday in response to the company's announcement of the launch of a new FDA-approved ophthalmic drug in collaboration with Formosa Pharmaceuticals.
2024-09-10 04:11
Formosa Pharma and Eyenovia Set to Launch New FDA-Approved Ophthalmic Drug in US
Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shipment to the United States of its new ophthalmic drug, Clobetasol Propionate Ophthalmic Suspension,
2024-09-09 15:02
Eyenovia CEO Michael M. Rowe Buys 50,000 Shares At An Average Price Of $0.57
Eyenovia CEO Michael M. Rowe Buys 50,000 Shares At An Average Price Of $0.57
2024-08-28 01:10
Eyenovia Raises $5.1 Million From Public Offering
11:54 AM EDT, 08/23/2024 (MT Newswires) -- Eyenovia (EYEN) said Friday that it closed its public offering of 12.85 million common shares at $0.40 apiece, raising about $5.1 million. The company said the net proceeds will be used to commercialize its postsurgical inflammation and pain treatment Mydco...
2024-08-23 23:54
Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?
Eyenovia Inc (NASDAQ:EYEN) stock is trading higher on Thursday after its plunge yesterday, with a session volume of 6.7 million, versus an average volume of 1.33 as per data from Benzinga Pro. On Wednesday, the ophthalmic technology company agreed to sell 12.85 million shares at $0.40 per share. The...
2024-08-23 02:20
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.08% to 40,867.75 while the NASDAQ rose 0.49% to 17,903.01. The S&P 500 also rose, gaining, 0.37% to 5,618.02. Check This Out: Executives Buying W. P. Carey And 2 Other...
2024-08-22 02:43
Crude Oil Down 1%; BigBear.ai Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 50 points on Wednesday. The Dow traded down 0.16% to 40,767.87 while the NASDAQ fell 0.14% to 17,792.53. The S&P 500 also fell, dropping, 0.06% to 5,593.92. Check This Out: Executives Buying W. P. Carey And 2...
2024-08-22 00:15
